| Financial Year |
March 31 2023 |
| Monetary Funds |
110,077,984.96 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
13,879,630.17 |
| Advances to Suppliers |
5,471,914.02 |
| Other Receivables |
4,354,201.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,996,882.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
188,173,029.83 |
| Total Current Assets |
328,953,643.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,595,585.89 |
| Investment Properties |
9,949,061.27 |
| Fixed Assetes |
562,871,974.25 |
| Under-construction Projects |
159,583,553.02 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
221,032,065.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,181,599.54 |
| Deferred Income Tax Assets |
4,425,041.76 |
| Other Non-Current Assets |
9,740,795.60 |
| Sub-Total of Non-Current Assets |
1,189,310,116.13 |
| Total Assets |
1,518,263,759.61 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
66,959,875.54 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,660,634.65 |
| Taxes Payable |
25,253,765.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,424,686.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
68,051.12 |
| Other Current Liabilities |
1,647,520.46 |
| Sub-Total of Current Liabilities |
183,126,468.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
16,861,575.95 |
| Sub-Total of Non-Current Liabilities |
29,583,157.14 |
| Total Liabilities |
212,709,626.03 |
| Paid-In Capital(Or Share Stock) |
110,680,000.00 |
| Capital Surplus |
333,293,772.61 |
| Surplus Reserve |
92,046,803.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
764,481,947.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,305,554,133.58 |
| Owner's Equity（Stockholder's Equity） |
1,305,554,133.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,518,263,759.61 |
